Loading…
Loading…
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability…
Is HQH's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Shares of abrdn Healthcare Investors (NYSE: HQH - Get Free Report) passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $22.43 and traded as low as $20.82. abrdn Healthcare Investors shares last traded at $20.8750, with a volume of 124,550 shares trading hands. abrdn Healthcare
Elevated interest rates push property cap rates higher, creating historically attractive entry multiples for institutional REIT buyers. CEFs transform low-yielding institutional REIT holdings into monthly cash checks. Cohen & Steers Quality Income Realty Fund Inc. holds high-conviction stakes in premier blue-chip REITs, consistently outperforming the passive VNQ benchmark across full economic cycles.
HQH benefits from healthcare sector mean reversion after lagging the broader market for a decade. abrdn Healthcare Investors provides a lucrative 12% forward distribution yield backed by a managed distribution policy. HQH focuses primarily on small and mid cap biotech while incorporating select larger cap holdings.
The "Base + Commission" Portfolio: Combining fixed-rate debt and preferreds with formulaic, NAV-linked variable CEFs creates a solid baseline of income with automated upside during bull markets. RVT's quarterly payout is tracking up from $0.31 to $0.33 in September, with additional regular and special year-end dividend upside in play. HQH's September payout is set to reach $0.66 per share – its highest single quarterly distribution since 2015 – with strong potential for a year-end special distribution.
Abrdn Healthcare Investors is a concentrated, actively managed biotech-focused CEF trading at a 6.4% discount to NAV. I rate HQH a Buy: the fund delivered a 56% NAV return in twelve months, benefiting from an FDA regulatory shift and M&A tailwinds. The near-12% distribution is entirely funded by realized gains, not return of capital, distinguishing HQH from most high-payout CEFs.